EMERGING TRENDS IN THE USE OF BIOLOGICS FOR SKIN DISEASES

Abstract

Background: Emerging biologic therapies represent a significant advancement in
dermatology, offering targeted treatment options for chronic, inflammatory skin diseases
which have traditionally been difficult to manage with conventional therapies. This review
paper evaluates recent progress in the application of biologic agent like Tumor Necrosis
Factor (TNF) inhibitors, Interleukin (IL)-12 and IL-23 inhibitors for conditions such as
psoriasis, atopic dermatitis, and other less common dermatoses. Drawing from a diverse array
of clinical trials and studies, we present a comprehensive overview of the efficacy, safety,
and patient response rates associated with these novel treatments. The insights gained
underscore the transformative potential of biologics in dermatology, paving the way for
personalized treatment paradigms and improved patient outcomes.